Melissa
Thursday, 12 October 2023 12:53
Nicola Fusco
Prof. Nicola Fusco is Director of the Division of Pathology at IEO European Institute of Oncology IRCCS, Milan, Italy and is an Associate Professor at the Department of Oncology and Hemato-Oncology, University of Milan. He also leads our IEO Biobank for Translational and Digital Medicine Unit. Prof. Fusco is a member of a global network of experts in predictive oncologic pathology, specializing in tissue and liquid biopsy. He is recognized as an expert in digital pathology and applications of artificial intelligence in diagnostic pathology.
Published in
Speakers
Tagged under
Thursday, 12 October 2023 12:52
Atocha Romero
Atocha Romero is a Laboratory Medicine specialist who holds a Ph.D. in Molecular Biology from Universidad Complutense de Madrid. Presently, Dr. Romero serves as the director of the Liquid Biopsy Laboratory (LBL), from the medical Oncology Department, at Puerta de Hierro Hospital, in Madrid. The LBL provides diagnostic services and undertakes research in the field of cancer biomarkers. Her research predominantly focuses on the applicability of liquid biopsies in lung cancer patients. Her research has consistently secured funding through competitive public grant calls. With over 90 publications in international journals to her name, she has also overseen multiple theses.
Published in
Speakers
Tagged under
Thursday, 12 October 2023 12:51
Andrea D'Ambrogio
Andrea earned his MSc in Biotechnology and PhD form the University of Trieste in Italy. During his postdocs at University of Massachussetts in the US and Laboratory of Molecular Biology in Cambridge UK he developed NGS library prep methods to clone small RNAs and RNAs attached to RNA binding proteins uncovering aberrant gene regulation of genes such as p53. He then moved to industry to Horizon Discovery in Cambridge UK to develop and launch several reference standards (including liquid biopsy!) widely used by molecular diagnostics technology developers such as Thermo, Illumina and Archer to set-up their assays, and now used in external quality assessment schemes to test labs ability to call the right alterations in cancer patient samples. After working on exosomes for a small Italian startup then acquired by Lonza he now works in Precision Oncology at Roche/Foundation Medicine where he tries every day to ‘do now what patients need next’.
Published in
Speakers
Tagged under
Thursday, 12 October 2023 12:50
Valsamo Anagnostou
Dr. Anagnostou is an Associate Professor of Oncology, director of the Thoracic Oncology Biorepository, leader of Precision Oncology Analytics and co-leader of the Molecular Tumor Board and the Thoracic Oncology Precision Medicine Center of Excellence in the Sidney Kimmel Cancer Center at Johns Hopkins. She graduated from Medical School of the National and Kapodistrian University of Athens, Greece and received a PhD from the same institution. After completing her internal medicine residency at Yale-New Haven Hospital, she subsequently trained in Medical Oncology at Johns Hopkins. Dr. Anagnostou is a translational cancer investigator, focusing on large-scale genomic and liquid biopsy analyses in human cancers. Her group has discovered novel genomic mechanisms of response and resistance to immunotherapy and her research is particularly focused on understanding the molecular mechanisms of response and resistance to these therapies, capturing these by minimally invasive methods and translating this knowledge into novel technologies and innovative therapeutic approaches for cancer patients. She is the international study chair of the first ctDNA-based molecular response adaptive immuno-chemotherapy clinical trial for metastatic non-small cell lung cancer (NCT04093167). Her long
term goal is to transform medical oncology to personalized molecular oncology, where treatment decisions are tailored to cancer genomics and molecular real-time response assessments informed by liquid biopsies.
Published in
Speakers
Tagged under
Thursday, 12 October 2023 12:50
Clara Mayo
Dr Clara Mayo holds a PhD in Biological Sciences from Pompeu Fabra University, Barcelona and has over 15 years’ experience in translational cancer research, basically focused on analysis of molecular biomarkers with clinical applications in circulating free DNA of cancer patients. She has coauthored more than 50 publications in renowned scientific journals. She is a member of AACR (American Association for Cancer Research), GEM (Spanish Melanoma Group), ISLB (International Society of Liquid Biopsy). Actually, is the executive director at Pangea oncology laboratory.
Summary of Pangaea Oncology
Pangaea Oncology is a company focused on Precision Oncology, which offers both patients and pharmaceutical companies different services with the aim of improving the survival of cancer patients, their response to treatments and their quality of life.
The company has two main areas of activity interrelated, such as the clinical care division and the laboratory, that provides 3 main services: molecular diagnostic reference laboratory for both patients and industry, pre-treatment services (clinic to industry) and diagnostic consultancy.
Additionally, Pangaea Oncology has a R&D division focused on diagnostic tools, highly focused on predictive models in liquid biopsy and massive sequencing and development of tools for R&D applied in pre-clinical.
Published in
Speakers
Tagged under
Thursday, 12 October 2023 12:50
Ekaterina Pisareva
Dr. Ekaterina Pisareva has MD and PhD degrees in molecular biology, giving her both medical and scientific expertise. Her doctoral research focused on the study of genetic alterations in tumors and the development of genetic diagnostic tests for personalized medicine. Her postdoctoral work was focused on fundamental research of the structure and production of circulating DNA in blood. With six years’ experience in the field of circulating DNA analysis, she has been actively involved in national and international translational projects, specifically in clinical studies applying circulating DNA testing as a tool for liquid biopsy analysis in oncology. Currently, Dr. Pisareva is affiliated with the Montpellier Cancer Research Institute in France.
Published in
Speakers
Tagged under
